Flawless: From measuring failure to building quality robustness in pharma

Flawless: From measuring failure to building quality robustness in pharma

Having zero errors should be the one overriding objective for quality in the pharmaceutical industry. We highlight how companies can shift their emphasis from "eternal vigilance" to "production system design," building more robust products and processes, and aiming for performance that comes as close as possible to "flawless."